Back to results
US 12,643,860 B2Granted
Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst
AssigneeBayer Aktiengesellschaft
InventorsChristoph Schotes, Dirk Eckart Brohm, Johannes Schranck
Life of this patent
Estimating the term…
Abstract
The invention relates to a process for preparing optically active 4-substituted 1,2,3,4-tetrahydroquinolines comprising enantioselective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium (P,N)-ligand catalyst.
Claims14
A process for preparing a compound of the formula (Ia) or (Ib),
- wherein
- R1 is C1-C6-alkyl,
- R2 and R3 are the same and are selected from the group consisting of C1-C6-alkyl,
- R4 is C1-C6-alkyl,
- n is 0 or 1,
- each substituent R5, if present, is independently selected from the group consisting of halogen, comprising enantioselective hydrogenation of a compound of the formula (II)
- wherein the substituents R1, R2, R3, R4, R5 and the integer n are each as defined for the compound of the formula (Ia) or (Ib),
- in presence of a chiral iridium catalyst,
- characterized in that the chiral iridium catalyst comprises a chiral ligand of the formula (IIIa) or (IIIb)
- wherein
- R6 and R7 are independently from one another selected from consisting of hydrogen, C1-C6-alkyl, and C6-C14-aryl,
- wherein the C6-C14-aryl is optionally substituted by one to five substituents selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, and C1-C4-alkoxy,
- R8 is methyl,
- R9 and R10 are independently from one another selected from the group consisting of C1-C6-alkyl, and C3-C12-cycloalkyl, and
- m is 1 or 2.
12 more elements
Dependencies are inferred from the claim text.